DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - Niacin


Collection D4 : CTD
Chemical Name Niacin ( From PubChem : NICOTINIC ACID )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotNotApprovedApprovedApprovedApprovedNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
123.109 g/mol 1 3 0.7798 True
Structure
InChI InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)
InChIKey PVNIIMVLHYAWGP-UHFFFAOYSA-N
Links

Gene (55 / 169)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDaffects(cotreatment)ABCA1
D009525
CTDdecreases(expression)ABCA1
D009525
CTDincreases(expression)ABCA1
D009525
CTDaffects(binding)ADIPOQ
D009525
CTDincreases(reaction)ADIPOQ
D009525
CTDincreases(expression)ADIPOQ
D009525
CTDincreases(expression)ADIPOQ
D009525
CTDdecreases(reaction)AGT
D009525
CTDincreases(abundance)AGT
D009525
CTDdecreases(expression)AHSG
D009525
CTDdecreases(phosphorylation)AHSG
D009525
CTDaffects(cotreatment)APOA1
D009525
CTDincreases(expression)APOA1
D009525
CTDaffects(cotreatment)APOA1
D009525
CTDincreases(expression)APOA1
D009525
CTDaffects(cotreatment)APOA1
D009525
CTDincreases(expression)APOA1
D009525
CTDaffects(cotreatment)APOA1
D009525
CTDincreases(expression)APOA1
D009525
CTDincreases(expression)APOA1
D009525
CTDincreases(reaction)APOA1
D009525
CTDaffects(cotreatment)APOA1
D009525
CTDincreases(expression)APOA1
D009525
CTDincreases(reaction)APOA1
D009525
CTDincreases(expression)APOA1
D009525
CTDaffects(cotreatment)APOB
D009525
CTDdecreases(expression)APOB
D009525
CTDaffects(cotreatment)APOB
D009525
CTDdecreases(expression)APOB
D009525
CTDdecreases(expression)APOB
D009525
CTDdecreases(expression)ATP5B
D009525
CTDdecreases(reaction)CCL2
D009525
CTDincreases(expression)CCL2
D009525
CTDdecreases(expression)CCL2
D009525
CTDincreases(expression)CEBPA
D009525
CTDincreases(expression)CEBPD
D009525
CTDdecreases(expression)CPT2
D009525
CTDdecreases(expression)CRP
D009525
CTDaffects(cotreatment)CRP
D009525
CTDdecreases(expression)CRP
D009525
CTDincreases(reaction)CRP
D009525
CTDaffects(cotreatment)CXCL8
D009525
CTDdecreases(expression)CXCL8
D009525
CTDincreases(reaction)CXCL8
D009525
CTDdecreases(activity)DGAT2
D009525
CTDdecreases(chemical synthesis)DGAT2
D009525
CTDincreases(expression)F2R
D009525
CTDdecreases(expression)FASN
D009525
CTDdecreases(abundance)GCG
D009525
CTDdecreases(reaction)GCG
D009525
CTDincreases(secretion)GCG
D009525
CTDdecreases(abundance)GH1
D009525
CTDdecreases(reaction)GH1
D009525
CTDincreases(secretion)GH1
D009525
CTDincreases(activity)HCAR2
D009525
CTDincreases(expression)HCAR2
D009525
CTDincreases(reaction)HCAR2
D009525
CTDaffects(activity)HCAR2
D009525
CTDaffects(binding)HCAR2
D009525
CTDaffects(binding)HCAR2
D009525
CTDincreases(activity)HCAR2
D009525
CTDaffects(binding)HCAR2
D009525
CTDincreases(activity)HCAR2
D009525
CTDincreases(phosphorylation)HCAR2
D009525
CTDaffects(binding)HCAR2
D009525
CTDincreases(activity)HCAR2
D009525
CTDdecreases(reaction)HCAR2
D009525
CTDincreases(abundance)HCAR2
D009525
CTDincreases(activity)HCAR2
D009525
CTDincreases(activity)HCAR3
D009525
CTDincreases(reaction)HCAR3
D009525
CTDaffects(binding)HCAR3
D009525
CTDincreases(activity)HCAR3
D009525
CTDincreases(phosphorylation)HCAR3
D009525
CTDaffects(binding)HCAR3
D009525
CTDdecreases(reaction)ICAM1
D009525
CTDincreases(expression)ICAM1
D009525
CTDdecreases(reaction)ICAM1
D009525
CTDincreases(expression)ICAM1
D009525
CTDdecreases(expression)ICAM1
D009525
CTDdecreases(reaction)IFNG
D009525
CTDincreases(expression)IFNG
D009525
CTDdecreases(reaction)IL1B
D009525
CTDincreases(expression)IL1B
D009525
CTDaffects(cotreatment)IL1B
D009525
CTDdecreases(expression)IL1B
D009525
CTDincreases(reaction)IL1B
D009525
CTDaffects(cotreatment)IL6
D009525
CTDdecreases(expression)IL6
D009525
CTDincreases(reaction)IL6
D009525
CTDincreases(expression)LEP
D009525
CTDdecreases(activity)LIPE
D009525
CTDdecreases(expression)LIPE
D009525
CTDaffects(cotreatment)LPA
D009525
CTDdecreases(expression)LPA
D009525
CTDaffects(cotreatment)LPA
D009525
CTDdecreases(expression)LPA
D009525
CTDaffects(cotreatment)LPA
D009525
CTDdecreases(expression)LPA
D009525
CTDdecreases(expression)LPA
D009525
CTDaffects(binding)MAPK1
D009525
CTDincreases(activity)MAPK1
D009525
CTDincreases(phosphorylation)MAPK1
D009525
CTDdecreases(reaction)MAPK1
D009525
CTDaffects(binding)MAPK3
D009525
CTDincreases(activity)MAPK3
D009525
CTDincreases(phosphorylation)MAPK3
D009525
CTDdecreases(reaction)MAPK3
D009525
CTDincreases(expression)NR1H3
D009525
CTDincreases(reaction)NR1H3
D009525
CTDaffects(cotreatment)PARP1
D009525
CTDincreases(expression)PARP1
D009525
CTDdecreases(reaction)PECAM1
D009525
CTDincreases(expression)PECAM1
D009525
CTDdecreases(expression)PECAM1
D009525
CTDdecreases(expression)PLA2G7
D009525
CTDincreases(expression)PPARA
D009525
CTDdecreases(reaction)PPARG
D009525
CTDincreases(activity)PPARG
D009525
CTDincreases(expression)PPARG
D009525
CTDincreases(reaction)PPARG
D009525
CTDincreases(activity)PPARG
D009525
CTDincreases(expression)PPARG
D009525
CTDincreases(expression)PPARG
D009525
CTDincreases(expression)PPARG
D009525
CTDincreases(reaction)PPARG
D009525
CTDincreases(expression)PPARGC1A
D009525
CTDincreases(activity)PRKAA2
D009525
CTDaffects(binding)PTGDR
D009525
CTDdecreases(activity)PTGDR
D009525
CTDdecreases(response to substance)PTGDR
D009525
CTDincreases(activity)PTGDS
D009525
CTDincreases(reaction)PTGDS
D009525
CTDincreases(activity)PTGS1
D009525
CTDincreases(reaction)PTGS1
D009525
CTDdecreases(reaction)RELA
D009525
CTDincreases(activity)RELA
D009525
CTDdecreases(expression)RETN
D009525
CTDdecreases(reaction)SCARB1
D009525
CTDincreases(expression)SCARB1
D009525
CTDincreases(export)SCARB1
D009525
CTDincreases(reaction)SCARB1
D009525
CTDdecreases(reaction)SERPINE1
D009525
CTDincreases(expression)SERPINE1
D009525
CTDincreases(expression)SIRT2
D009525
CTDincreases(expression)SIRT4
D009525
CTDdecreases(reaction)TGFB1
D009525
CTDincreases(expression)TGFB1
D009525
CTDdecreases(reaction)TGFB1
D009525
CTDincreases(expression)TGFB1
D009525
CTDdecreases(reaction)TNF
D009525
CTDincreases(activity)TNF
D009525
CTDincreases(expression)TNF
D009525
CTDdecreases(reaction)TNF
D009525
CTDincreases(expression)TNF
D009525
CTDdecreases(reaction)TNF
D009525
CTDincreases(expression)TNF
D009525
CTDaffects(cotreatment)TNF
D009525
CTDdecreases(expression)TNF
D009525
CTDincreases(reaction)TNF
D009525
CTDdecreases(reaction)VCAM1
D009525
CTDincreases(expression)VCAM1
D009525
CTDincreases(expression)VTN
D009525
ChEMBLInhibition-CYP1A2
-Target : CHEMBL3356
ChEMBLInhibition-CYP2C19
-Target : CHEMBL3622
ChEMBLInhibition-CYP2C9
-Target : CHEMBL3397
ChEMBLInhibition-CYP2D6
-Target : CHEMBL289
ChEMBLInhibition-CYP3A4
-Target : CHEMBL340
ChEMBLInhibition-CYP3A4
-Target : CHEMBL340
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).